Edition:
United States

Profile: Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

14.54USD
4:00pm EDT
Change (% chg)

$-0.36 (-2.42%)
Prev Close
$14.90
Open
$14.93
Day's High
$14.95
Day's Low
$14.51
Volume
3,373,007
Avg. Vol
3,493,333
52-wk High
$44.41
52-wk Low
$14.30

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic medicines in a range of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. Its specialty medicines business focuses on delivering a range of solutions to patients and providers through medicines, devices and services in various regions and markets around the world. Its specialty medicines business includes its core therapeutic areas of central nervous system (CNS) and respiratory medicines with a focus on asthma and chronic obstructive pulmonary disease. It also has specialty products in oncology, women's health and selected other areas.

Company Address

Teva Pharmaceutical Industries Ltd

5 Basel St.,
P.O. Box 3190
PETAH TIKVA     49131
P: +9723.9267267
F: +9723.9234050

Company Web Links